| Rank | HUGOID | Symbol | Name | t+ | t- |
t+ uniq |
com mon |
b+ uniq |
b+ | b- | p-value | t-ratio | b-ratio |
enrichment folds |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6018 | IL6 | interleukin 6 (interferon, beta 2) | 1 | 171 | 1 | 0 | 25 | 25 | 143 | 1.30e-07 | 0.01 | 0.15 | 0.0 |
| 2 | 11892 | TNF | tumor necrosis factor (TNF superfamily, member 2) | 10 | 162 | 6 | 4 | 39 | 43 | 125 | 3.90e-07 | 0.06 | 0.26 | 0.2 |
| 3 | 9605 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 2 | 170 | 2 | 0 | 26 | 26 | 142 | 5.10e-07 | 0.01 | 0.15 | 0.1 |
| 4 | 1516 | CAT | catalase | 30 | 142 | 28 | 2 | 3 | 5 | 163 | 8.70e-06 | 0.17 | 0.03 | 5.9 |
| 5 | 4235 | GFAP | glial fibrillary acidic protein | 6 | 166 | 4 | 2 | 20 | 22 | 146 | 1.36e-03 | 0.03 | 0.13 | 0.3 |
| 6 | 31395 | COX8B | cytochrome c oxidase, subunit 8B pseudogene | 13 | 159 | 13 | 0 | 1 | 1 | 167 | 1.51e-03 | 0.08 | 0.01 | 12.7 |
| 7 | 5992 | IL1B | interleukin 1, beta | 4 | 168 | 2 | 2 | 16 | 18 | 150 | 1.70e-03 | 0.02 | 0.11 | 0.2 |
| 8 | 5438 | IFNG | interferon, gamma | 3 | 169 | 2 | 1 | 15 | 16 | 152 | 1.78e-03 | 0.02 | 0.10 | 0.2 |
| 9 | 11180 | SOD2 | superoxide dismutase 2, mitochondrial | 19 | 153 | 17 | 2 | 2 | 4 | 164 | 1.88e-03 | 0.11 | 0.02 | 4.6 |
| 10 | 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 91 | 81 | 88 | 3 | 59 | 62 | 106 | 3.30e-03 | 0.53 | 0.37 | 1.4 |
| 11 | 6014 | IL4 | interleukin 4 | 1 | 171 | 1 | 0 | 10 | 10 | 158 | 5.16e-03 | 0.01 | 0.06 | 0.1 |
| 12 | 6081 | INS | insulin | 2 | 170 | 2 | 0 | 12 | 12 | 156 | 5.81e-03 | 0.01 | 0.07 | 0.2 |
| 13 | 19986 | CYCS | cytochrome c, somatic | 20 | 152 | 19 | 1 | 5 | 6 | 162 | 7.02e-03 | 0.12 | 0.04 | 3.3 |
| 14 | 5962 | IL10 | interleukin 10 | 1 | 171 | 1 | 0 | 9 | 9 | 159 | 9.88e-03 | 0.01 | 0.05 | 0.1 |
| 15 | 1678 | CD4 | CD4 molecule | 1 | 171 | 1 | 0 | 8 | 8 | 160 | 1.87e-02 | 0.01 | 0.05 | 0.1 |
| 16 | 6001 | IL2 | interleukin 2 | 1 | 171 | 1 | 0 | 8 | 8 | 160 | 1.87e-02 | 0.01 | 0.05 | 0.1 |
| 17 | 118 | ACO2 | aconitase 2, mitochondrial | 9 | 163 | 8 | 1 | 0 | 1 | 167 | 1.98e-02 | 0.05 | 0.01 | 8.8 |
| 18 | 1511 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | 6 | 166 | 6 | 0 | 0 | 0 | 168 | 2.99e-02 | 0.03 | 0.00 | bZero |
| 19 | 2169 | CNTF | ciliary neurotrophic factor | 1 | 171 | 1 | 0 | 7 | 7 | 161 | 3.51e-02 | 0.01 | 0.04 | 0.1 |
| 20 | 12805 | XDH | xanthine dehydrogenase | 8 | 164 | 7 | 1 | 0 | 1 | 167 | 3.67e-02 | 0.05 | 0.01 | 7.8 |
| 21 | 1613 | CCS | copper chaperone for superoxide dismutase | 8 | 164 | 8 | 0 | 1 | 1 | 167 | 3.67e-02 | 0.05 | 0.01 | 7.8 |
| 22 | 7873 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | 20 | 152 | 18 | 2 | 32 | 34 | 134 | 3.74e-02 | 0.12 | 0.20 | 0.6 |
| 23 | 5991 | IL1A | interleukin 1, alpha | 2 | 170 | 1 | 1 | 7 | 8 | 160 | 0.06 | 0.01 | 0.05 | 0.2 |
| 24 | 11138 | SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 5 | 167 | 5 | 0 | 0 | 0 | 168 | 0.06 | 0.03 | 0.00 | bZero |
| 25 | 1991 | CKB | creatine kinase, brain | 5 | 167 | 5 | 0 | 0 | 0 | 168 | 0.06 | 0.03 | 0.00 | bZero |
| 26 | 1693 | CD68 | CD68 molecule | 1 | 171 | 0 | 1 | 5 | 6 | 162 | 0.06 | 0.01 | 0.04 | 0.2 |
| 27 | 1509 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1 | 171 | 1 | 0 | 6 | 6 | 162 | 0.06 | 0.01 | 0.04 | 0.2 |
| 28 | 11917 | TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 1 | 171 | 1 | 0 | 6 | 6 | 162 | 0.06 | 0.01 | 0.04 | 0.2 |
| 29 | 9461 | PRPH | peripherin | 1 | 171 | 0 | 1 | 4 | 5 | 163 | 0.12 | 0.01 | 0.03 | 0.2 |
| 30 | 3951 | FXN | frataxin | 6 | 166 | 5 | 1 | 0 | 1 | 167 | 0.12 | 0.03 | 0.01 | 5.9 |
| 31 | 4623 | GSR | glutathione reductase | 6 | 166 | 6 | 0 | 1 | 1 | 167 | 0.12 | 0.03 | 0.01 | 5.9 |
| 32 | 1912 | CHAT | choline acetyltransferase | 4 | 168 | 4 | 0 | 0 | 0 | 168 | 0.12 | 0.02 | 0.00 | bZero |
| 33 | 5464 | IGF1 | insulin-like growth factor 1 (somatomedin C) | 3 | 169 | 2 | 1 | 7 | 8 | 160 | 0.14 | 0.02 | 0.05 | 0.4 |
| 34 | 11782 | TH | tyrosine hydroxylase | 3 | 169 | 3 | 0 | 8 | 8 | 160 | 0.14 | 0.02 | 0.05 | 0.4 |
| 35 | 11919 | CD40 | CD40 molecule, TNF receptor superfamily member 5 | 3 | 169 | 3 | 0 | 8 | 8 | 160 | 0.14 | 0.02 | 0.05 | 0.4 |
| 36 | 7808 | NGF | nerve growth factor (beta polypeptide) | 6 | 166 | 5 | 1 | 11 | 12 | 156 | 0.15 | 0.03 | 0.07 | 0.5 |
| 37 | 4232 | GDNF | glial cell derived neurotrophic factor | 2 | 170 | 2 | 0 | 6 | 6 | 162 | 0.17 | 0.01 | 0.04 | 0.3 |
| 38 | 5013 | HMOX1 | heme oxygenase (decycling) 1 | 7 | 165 | 6 | 1 | 1 | 2 | 166 | 0.17 | 0.04 | 0.01 | 3.4 |
| 39 | 132 | ACTB | actin, beta | 1 | 171 | 1 | 0 | 4 | 4 | 164 | 0.21 | 0.01 | 0.02 | 0.2 |
| 40 | 2898 | DLD | dihydrolipoamide dehydrogenase | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 41 | 4624 | GSS | glutathione synthetase | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 42 | 412 | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 43 | 10990 | SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 44 | 16554 | SLC25A6P1 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, pseudogene 1 | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 45 | 6877 | MAPK3 | mitogen-activated protein kinase 3 | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 46 | 17169 | PRDX4 | peroxiredoxin 4 | 3 | 169 | 3 | 0 | 0 | 0 | 168 | 0.25 | 0.02 | 0.00 | bZero |
| 47 | 12680 | VEGFA | vascular endothelial growth factor A | 4 | 168 | 4 | 0 | 8 | 8 | 160 | 0.25 | 0.02 | 0.05 | 0.5 |
| 48 | 6893 | MAPT | microtubule-associated protein tau | 9 | 163 | 7 | 2 | 2 | 4 | 164 | 0.26 | 0.05 | 0.02 | 2.2 |
| 49 | 8975 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 2 | 170 | 2 | 0 | 5 | 5 | 163 | 0.28 | 0.01 | 0.03 | 0.4 |
| 50 | 8768 | AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | 6 | 166 | 5 | 1 | 1 | 2 | 166 | 0.28 | 0.03 | 0.01 | 2.9 |
| 51 | 620 | APP | amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) | 22 | 150 | 20 | 2 | 27 | 29 | 139 | 0.29 | 0.13 | 0.17 | 0.7 |
| 52 | 613 | APOE | apolipoprotein E | 7 | 165 | 4 | 3 | 8 | 11 | 157 | 0.34 | 0.04 | 0.07 | 0.6 |
| 53 | 437 | ALPI | alkaline phosphatase, intestinal | 1 | 171 | 1 | 0 | 3 | 3 | 165 | 0.37 | 0.01 | 0.02 | 0.3 |
| 54 | 936 | BAD | BCL2-antagonist of cell death | 1 | 171 | 0 | 1 | 2 | 3 | 165 | 0.37 | 0.01 | 0.02 | 0.3 |
| 55 | 6207 | JUP | junction plakoglobin | 1 | 171 | 1 | 0 | 3 | 3 | 165 | 0.37 | 0.01 | 0.02 | 0.3 |
| 56 | 2295 | CP | ceruloplasmin (ferroxidase) | 4 | 168 | 4 | 0 | 1 | 1 | 167 | 0.37 | 0.02 | 0.01 | 3.9 |
| 57 | 14133 | SEPX1 | selenoprotein X, 1 | 4 | 168 | 3 | 1 | 0 | 1 | 167 | 0.37 | 0.02 | 0.01 | 3.9 |
| 58 | 25806 | GSTCD | glutathione S-transferase, C-terminal domain containing | 4 | 168 | 3 | 1 | 0 | 1 | 167 | 0.37 | 0.02 | 0.01 | 3.9 |
| 59 | 4827 | HBB | hemoglobin, beta | 4 | 168 | 4 | 0 | 1 | 1 | 167 | 0.37 | 0.02 | 0.01 | 3.9 |
| 60 | 2244 | COQ7 | coenzyme Q7 homolog, ubiquinone (yeast) | 4 | 168 | 3 | 1 | 0 | 1 | 167 | 0.37 | 0.02 | 0.01 | 3.9 |
| 61 | 1499 | CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 5 | 167 | 4 | 1 | 7 | 8 | 160 | 0.41 | 0.03 | 0.05 | 0.6 |
| 62 | 12435 | TXN | thioredoxin | 5 | 167 | 4 | 1 | 1 | 2 | 166 | 0.45 | 0.03 | 0.01 | 2.4 |
| 63 | 11936 | FASLG | Fas ligand (TNF superfamily, member 6) | 3 | 169 | 3 | 0 | 5 | 5 | 163 | 0.50 | 0.02 | 0.03 | 0.6 |
| 64 | 11506 | SYP | synaptophysin | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 65 | 798 | ATOX1 | ATX1 antioxidant protein 1 homolog (yeast) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 66 | 4057 | G6PD | glucose-6-phosphate dehydrogenase | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 67 | 20374 | GSX1 | GS homeobox 1 | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 68 | 12468 | UBC | ubiquitin C | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 69 | 3229 | EGF | epidermal growth factor (beta-urogastrone) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 70 | 795 | ATM | ataxia telangiectasia mutated | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 71 | 14374 | NLRP1 | NLR family, pyrin domain containing 1 | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 72 | 18985 | DCXR | dicarbonyl/L-xylulose reductase | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 73 | 381 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 74 | 2903 | DLG4 | discs, large homolog 4 (Drosophila) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 75 | 7711 | NDUFS4 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 76 | 9353 | PRDX2 | peroxiredoxin 2 | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 77 | 2422 | CS | citrate synthase | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 78 | 4092 | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 79 | 7553 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 80 | 1784 | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 81 | 949 | BAK1 | BCL2-antagonist/killer 1 | 2 | 170 | 2 | 0 | 0 | 0 | 168 | 0.50 | 0.01 | 0.00 | bZero |
| 82 | 6204 | JUN | jun oncogene | 6 | 166 | 5 | 1 | 2 | 3 | 165 | 0.50 | 0.03 | 0.02 | 2.0 |
| 83 | 11998 | TP53 | tumor protein p53 | 6 | 166 | 5 | 1 | 2 | 3 | 165 | 0.50 | 0.03 | 0.02 | 2.0 |
| 84 | 1504 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | 11 | 161 | 11 | 0 | 14 | 14 | 154 | 0.54 | 0.06 | 0.08 | 0.8 |
| 85 | 990 | BCL2 | B-cell CLL/lymphoma 2 | 16 | 156 | 15 | 1 | 11 | 12 | 156 | 0.56 | 0.09 | 0.07 | 1.3 |
| 86 | 3796 | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | 6 | 166 | 5 | 1 | 7 | 8 | 160 | 0.60 | 0.03 | 0.05 | 0.7 |
| 87 | 1033 | BDNF | brain-derived neurotrophic factor | 7 | 165 | 7 | 0 | 9 | 9 | 159 | 0.62 | 0.04 | 0.05 | 0.8 |
| 88 | 3415 | EPO | erythropoietin | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 89 | 3573 | FADD | Fas (TNFRSF6)-associated via death domain | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 90 | 5253 | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 91 | 23212 | MYH14 | myosin, heavy chain 14 | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 92 | 11742 | TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 93 | 3493 | ETV4 | ets variant gene 4 (E1A enhancer binding protein, E1AF) | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 94 | 11609 | TBXAS1 | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 95 | 2355 | CRH | corticotropin releasing hormone | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 96 | 25079 | CCDC34 | coiled-coil domain containing 34 | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 97 | 2432 | CSF1 | colony stimulating factor 1 (macrophage) | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 98 | 8024 | NTF4 | neurotrophin 4 | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 99 | 8031 | NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 100 | 21285 | ADCY10 | adenylate cyclase 10 (soluble) | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 101 | 9065 | PLCG1 | phospholipase C, gamma 1 | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 102 | 9801 | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 103 | 9201 | POMC | proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 104 | 2615 | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 105 | 7737 | NEFH | neurofilament, heavy polypeptide 200kDa | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 106 | 11205 | SP1 | Sp1 transcription factor | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 107 | 7577 | MYH7 | myosin, heavy chain 7, cardiac muscle, beta | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 108 | 8607 | PARK2 | Parkinson disease (autosomal recessive, juvenile) 2, parkin | 1 | 171 | 0 | 1 | 1 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 109 | 3665 | FGF1 | fibroblast growth factor 1 (acidic) | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 110 | 2577 | CYBA | cytochrome b-245, alpha polypeptide | 1 | 171 | 1 | 0 | 2 | 2 | 166 | 0.62 | 0.01 | 0.01 | 0.5 |
| 111 | 399 | ALB | albumin | 10 | 162 | 10 | 0 | 7 | 7 | 161 | 0.62 | 0.06 | 0.04 | 1.4 |
| 112 | 4638 | GSTP1 | glutathione S-transferase pi | 3 | 169 | 3 | 0 | 1 | 1 | 167 | 0.62 | 0.02 | 0.01 | 2.9 |
| 113 | 11740 | TF | transferrin | 3 | 169 | 3 | 0 | 1 | 1 | 167 | 0.62 | 0.02 | 0.01 | 2.9 |
| 114 | 576 | APAF1 | apoptotic peptidase activating factor 1 | 3 | 169 | 2 | 1 | 0 | 1 | 167 | 0.62 | 0.02 | 0.01 | 2.9 |
| 115 | 4553 | GPX1 | glutathione peroxidase 1 | 3 | 169 | 3 | 0 | 1 | 1 | 167 | 0.62 | 0.02 | 0.01 | 2.9 |
| 116 | 7661 | NCF2 | neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) | 2 | 170 | 1 | 1 | 2 | 3 | 165 | 0.68 | 0.01 | 0.02 | 0.7 |
| 117 | 2345 | CREB1 | cAMP responsive element binding protein 1 | 2 | 170 | 1 | 1 | 2 | 3 | 165 | 0.68 | 0.01 | 0.02 | 0.7 |
| 118 | 2578 | CYBB | cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 2 | 170 | 1 | 1 | 2 | 3 | 165 | 0.68 | 0.01 | 0.02 | 0.7 |
| 119 | 7739 | NEFL | neurofilament, light polypeptide 68kDa | 2 | 170 | 2 | 0 | 3 | 3 | 165 | 0.68 | 0.01 | 0.02 | 0.7 |
| 120 | 7897 | NPC1 | Niemann-Pick disease, type C1 | 2 | 170 | 0 | 2 | 1 | 3 | 165 | 0.68 | 0.01 | 0.02 | 0.7 |
| 121 | 4341 | GLUL | glutamate-ammonia ligase (glutamine synthetase) | 4 | 168 | 3 | 1 | 1 | 2 | 166 | 0.68 | 0.02 | 0.01 | 2.0 |
| 122 | 4572 | GRIA2 | glutamate receptor, ionotropic, AMPA 2 | 4 | 168 | 4 | 0 | 2 | 2 | 166 | 0.68 | 0.02 | 0.01 | 2.0 |
| 123 | 9393 | PRKCA | protein kinase C, alpha | 5 | 167 | 4 | 1 | 2 | 3 | 165 | 0.72 | 0.03 | 0.02 | 1.6 |
| 124 | 14874 | NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | 5 | 167 | 4 | 1 | 5 | 6 | 162 | 0.77 | 0.03 | 0.04 | 0.8 |
| 125 | 727 | ARTN | artemin | 8 | 164 | 7 | 1 | 8 | 9 | 159 | 0.81 | 0.05 | 0.05 | 0.9 |
| 126 | 7794 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 10 | 162 | 9 | 1 | 10 | 11 | 157 | 0.82 | 0.06 | 0.07 | 0.9 |
| 127 | 10417 | RPS27A | ribosomal protein S27a | 10 | 162 | 8 | 2 | 9 | 11 | 157 | 0.82 | 0.06 | 0.07 | 0.9 |
| 128 | 7872 | NOS1 | nitric oxide synthase 1 (neuronal) | 12 | 160 | 11 | 1 | 9 | 10 | 158 | 0.83 | 0.07 | 0.06 | 1.2 |
| 129 | 17937 | CUZD1 | CUB and zona pellucida-like domains 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 130 | 3650 | FEN1 | flap structure-specific endonuclease 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 131 | 9588 | PTEN | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 132 | 443 | ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | 2 | 170 | 1 | 1 | 1 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 133 | 959 | BAX | BCL2-associated X protein | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 134 | 9717 | PXMP3 | peroxisomal membrane protein 3, 35kDa (Zellweger syndrome) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 135 | 10289 | RPA1 | replication protein A1, 70kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 136 | 13509 | AVEN | apoptosis, caspase activation inhibitor | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 137 | 6843 | MAP2K3 | mitogen-activated protein kinase kinase 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 138 | 9950 | RECQL5 | RecQ protein-like 5 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 139 | 9752 | QDPR | quinoid dihydropteridine reductase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 140 | 7707 | NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 141 | 3435 | ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 142 | 6781 | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 143 | 6871 | MAPK1 | mitogen-activated protein kinase 1 | 9 | 163 | 7 | 2 | 7 | 9 | 159 | 1.00 | 0.05 | 0.05 | 1.0 |
| 144 | 7460 | MT-ND4L | mitochondrially encoded NADH dehydrogenase 4L | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 145 | 20473 | BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 146 | 17348 | PRPF3 | PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 147 | 2773 | DFFB | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 148 | 7462 | MT-ND6 | mitochondrially encoded NADH dehydrogenase 6 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 149 | 8032 | NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 150 | 7211 | MPG | N-methylpurine-DNA glycosylase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 151 | 8979 | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 152 | 429 | ALOX12 | arachidonate 12-lipoxygenase | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 153 | 5269 | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 154 | 7473 | MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 155 | 12642 | VAMP1 | vesicle-associated membrane protein 1 (synaptobrevin 1) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 156 | 1546 | SERPINH1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 157 | 9208 | POR | P450 (cytochrome) oxidoreductase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 158 | 7427 | MT-CYB | mitochondrially encoded cytochrome b | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 159 | 12343 | TRNAR1 | transfer RNA arginine 1 (anticodon UCU) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 160 | 4983 | HMGB1 | high-mobility group box 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 161 | 3711 | FKBP1A | FK506 binding protein 1A, 12kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 162 | 14581 | PINK1 | PTEN induced putative kinase 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 163 | 11427 | STUB1 | STIP1 homology and U-box containing protein 1 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 164 | 939 | BAG3 | BCL2-associated athanogene 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 165 | 24959 | GSX2 | GS homeobox 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 166 | 1317 | C2orf3 | chromosome 2 open reading frame 3 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 167 | 30862 | UQCR | ubiquinol-cytochrome c reductase, 6.4kDa subunit | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 168 | 992 | BCL2L1 | BCL2-like 1 | 3 | 169 | 3 | 0 | 3 | 3 | 165 | 1.00 | 0.02 | 0.02 | 1.0 |
| 169 | 8023 | NTF3 | neurotrophin 3 | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 170 | 6307 | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 171 | 10886 | SIRT2 | sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 172 | 249 | ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 173 | 1503 | CASP2 | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 174 | 5261 | HSPD1 | heat shock 60kDa protein 1 (chaperonin) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 175 | 9655 | PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 176 | 2728 | DDOST | dolichyl-diphosphooligosaccharide-protein glycosyltransferase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 177 | 1325 | C4BPA | complement component 4 binding protein, alpha | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 178 | 16769 | GORASP1 | golgi reassembly stacking protein 1, 65kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 179 | 3768 | FMN1 | formin 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 180 | 12517 | UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 181 | 9948 | RECQL | RecQ protein-like (DNA helicase Q1-like) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 182 | 4605 | GRP | gastrin-releasing peptide | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 183 | 21354 | TICAM2 | toll-like receptor adaptor molecule 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 184 | 12420 | TUFM | Tu translation elongation factor, mitochondrial | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 185 | 7458 | MT-ND3 | mitochondrially encoded NADH dehydrogenase 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 186 | 12408 | TUBA3C | tubulin, alpha 3c | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 187 | 20778 | TUBB | tubulin, beta | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 188 | 7097 | MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 189 | 1101 | BRCA2 | breast cancer 2, early onset | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 190 | 9508 | PSEN1 | presenilin 1 (Alzheimer disease 3) | 5 | 167 | 4 | 1 | 4 | 5 | 163 | 1.00 | 0.03 | 0.03 | 1.0 |
| 191 | 13748 | DLEU2 | deleted in lymphocytic leukemia, 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 192 | 16014 | CASD1 | CAS1 domain containing 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 193 | 11007 | SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 194 | 6834 | MAOB | monoamine oxidase B | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 195 | 16400 | NLRP3 | NLR family, pyrin domain containing 3 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 196 | 6879 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 197 | 7459 | MT-ND4 | mitochondrially encoded NADH dehydrogenase 4 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 198 | 3062 | DUOX1 | dual oxidase 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 199 | 270 | PARP1 | poly (ADP-ribose) polymerase family, member 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 200 | 9824 | RAD52 | RAD52 homolog (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 201 | 391 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 8 | 164 | 6 | 2 | 6 | 8 | 160 | 1.00 | 0.05 | 0.05 | 1.0 |
| 202 | 10963 | SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 203 | 7212 | MPHOSPH1 | M-phase phosphoprotein 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 204 | 1706 | CD8A | CD8a molecule | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 205 | 11763 | TFRC | transferrin receptor (p90, CD71) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 206 | 1848 | CEL | carboxyl ester lipase (bile salt-stimulated lipase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 207 | 9816 | RAD50 | RAD50 homolog (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 208 | 3763 | FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 209 | 7876 | NOS3 | nitric oxide synthase 3 (endothelial cell) | 5 | 167 | 3 | 2 | 3 | 5 | 163 | 1.00 | 0.03 | 0.03 | 1.0 |
| 210 | 2859 | DHCR24 | 24-dehydrocholesterol reductase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 211 | 9257 | PPID | peptidylprolyl isomerase D (cyclophilin D) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 212 | 61 | ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 213 | 12609 | USP11 | ubiquitin specific peptidase 11 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 214 | 10840 | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 215 | 4323 | GLO1 | glyoxalase I | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 216 | 7419 | MT-CO1 | mitochondrially encoded cytochrome c oxidase I | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 217 | 30000 | BBS9 | Bardet-Biedl syndrome 9 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 218 | 16731 | FBXO32 | F-box protein 32 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 219 | 11655 | TCP1 | t-complex 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 220 | 841 | ATP5G1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 221 | 13273 | DUOX2 | dual oxidase 2 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 222 | 6881 | MAPK8 | mitogen-activated protein kinase 8 | 3 | 169 | 3 | 0 | 3 | 3 | 165 | 1.00 | 0.02 | 0.02 | 1.0 |
| 223 | 10939 | SLC1A1 | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 224 | 11240 | SPHK1 | sphingosine kinase 1 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 225 | 7377 | MSRA | methionine sulfoxide reductase A | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 226 | 1618 | CCT5 | chaperonin containing TCP1, subunit 5 (epsilon) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 227 | 21148 | RNF123 | ring finger protein 123 | 2 | 170 | 1 | 1 | 1 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 228 | 23696 | TIPARP | TCDD-inducible poly(ADP-ribose) polymerase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 229 | 8978 | PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 230 | 9380 | PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 231 | 2983 | DNTT | deoxynucleotidyltransferase, terminal | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 232 | 11920 | FAS | Fas (TNF receptor superfamily, member 6) | 8 | 164 | 8 | 0 | 7 | 7 | 161 | 1.00 | 0.05 | 0.04 | 1.1 |
| 233 | 784 | ATF2 | activating transcription factor 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 234 | 6915 | MB | myoglobin | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 235 | 8806 | PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 236 | 7804 | NFYA | nuclear transcription factor Y, alpha | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 237 | 9413 | PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 238 | 9354 | PRDX3 | peroxiredoxin 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 239 | 8988 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 240 | 380 | AKR1A1 | aldo-keto reductase family 1, member A1 (aldehyde reductase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 241 | 10876 | SIGLEC7 | sialic acid binding Ig-like lectin 7 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 242 | 12022 | TPT1 | tumor protein, translationally-controlled 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 243 | 6817 | MAL | mal, T-cell differentiation protein | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 244 | 14929 | SIRT1 | sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae) | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 245 | 11049 | SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 246 | 4646 | GTF2A1 | general transcription factor IIA, 1, 19/37kDa | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 247 | 7715 | NDUFS8 | NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 248 | 7965 | NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 249 | 4330 | GLRX | glutaredoxin (thioltransferase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 250 | 6780 | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 251 | 5385 | IDH3B | isocitrate dehydrogenase 3 (NAD+) beta | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 252 | 9509 | PSEN2 | presenilin 2 (Alzheimer disease 4) | 3 | 169 | 2 | 1 | 1 | 2 | 166 | 1.00 | 0.02 | 0.01 | 1.5 |
| 253 | 4851 | HTT | huntingtin | 3 | 169 | 2 | 1 | 2 | 3 | 165 | 1.00 | 0.02 | 0.02 | 1.0 |
| 254 | 10451 | RRM1 | ribonucleotide reductase M1 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 255 | 10941 | SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 256 | 3346 | ENDOG | endonuclease G | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 257 | 5472 | IGFBP3 | insulin-like growth factor binding protein 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 258 | 15917 | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 259 | 11014 | SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 260 | 30213 | ATP13A2 | ATPase type 13A2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 261 | 7545 | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 262 | 17128 | SLC39A3 | solute carrier family 39 (zinc transporter), member 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 263 | 24190 | CAMK2N1 | calcium/calmodulin-dependent protein kinase II inhibitor 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 264 | 9817 | RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 265 | 2874 | NQO1 | NAD(P)H dehydrogenase, quinone 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 266 | 3189 | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 267 | 1260 | C21orf2 | chromosome 21 open reading frame 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 268 | 12716 | TRPV1 | transient receptor potential cation channel, subfamily V, member 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 269 | 6840 | MAP2K1 | mitogen-activated protein kinase kinase 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 270 | 6776 | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 271 | 1062 | BLVRA | biliverdin reductase A | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 272 | 8548 | P4HB | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 273 | 2579 | CYC1 | cytochrome c-1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 274 | 11517 | TAC1 | tachykinin, precursor 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 275 | 2206 | COL4A4 | collagen, type IV, alpha 4 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 276 | 445 | SETX | senataxin | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 277 | 9122 | PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 278 | 9388 | PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 279 | 11729 | TERF2 | telomeric repeat binding factor 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 280 | 15814 | ACSS2 | acyl-CoA synthetase short-chain family member 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 281 | 587 | APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 282 | 19374 | NKRF | NFKB repressing factor | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 283 | 7455 | MT-ND1 | mitochondrially encoded NADH dehydrogenase 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 284 | 8784 | PDE5A | phosphodiesterase 5A, cGMP-specific | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 285 | 5232 | HSPA1A | heat shock 70kDa protein 1A | 6 | 166 | 5 | 1 | 4 | 5 | 163 | 1.00 | 0.03 | 0.03 | 1.2 |
| 286 | 7734 | NEFM | neurofilament, medium polypeptide 150kDa | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 287 | 5241 | HSPA8 | heat shock 70kDa protein 8 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 288 | 6876 | MAPK14 | mitogen-activated protein kinase 14 | 6 | 166 | 6 | 0 | 6 | 6 | 162 | 1.00 | 0.03 | 0.04 | 1.0 |
| 289 | 1773 | CDK4 | cyclin-dependent kinase 4 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 290 | 1058 | BLM | Bloom syndrome | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 291 | 14931 | SIRT3 | sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 292 | 26333 | SRFBP1 | serum response factor binding protein 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 293 | 6563 | LGALS3 | lectin, galactoside-binding, soluble, 3 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 294 | 1442 | CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 295 | 7415 | MT-ATP8 | mitochondrially encoded ATP synthase 8 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 296 | 9411 | PRKCSH | protein kinase C substrate 80K-H | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 297 | 14180 | PDIA2 | protein disulfide isomerase family A, member 2 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 298 | 1158 | TSPO | translocator protein (18kDa) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 299 | 5173 | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 300 | 4739 | H2AFX | H2A histone family, member X | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 301 | 11121 | SMPD2 | sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 302 | 4055 | XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 (Ku autoantigen, 70kDa) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 303 | 12513 | UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 304 | 9253 | PPIA | peptidylprolyl isomerase A (cyclophilin A) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 305 | 333 | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 306 | 9827 | RAD9A | RAD9 homolog A (S. pombe) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 307 | 7782 | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 308 | 16753 | PRDX6 | peroxiredoxin 6 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 309 | 10945 | SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 310 | 7797 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 311 | 2264 | COX17 | COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 312 | 4250 | GGT1 | gamma-glutamyltransferase 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 313 | 10780 | SFRS1 | splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 314 | 4571 | GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 8 | 164 | 7 | 1 | 6 | 7 | 161 | 1.00 | 0.05 | 0.04 | 1.1 |
| 315 | 5244 | HSPA9 | heat shock 70kDa protein 9 (mortalin) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 316 | 12780 | WNT2 | wingless-type MMTV integration site family member 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 317 | 3013 | DPYS | dihydropyrimidinase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 318 | 4331 | GLS | glutaminase | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 319 | 10940 | SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 9 | 163 | 9 | 0 | 9 | 9 | 159 | 1.00 | 0.05 | 0.05 | 1.0 |
| 320 | 19737 | TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 321 | 7662 | NCF4 | neutrophil cytosolic factor 4, 40kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 322 | 5014 | HMOX2 | heme oxygenase (decycling) 2 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 323 | 4311 | GCLC | glutamate-cysteine ligase, catalytic subunit | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 324 | 7660 | NCF1 | neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1) | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 325 | 23177 | KEAP1 | kelch-like ECH-associated protein 1 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 326 | 24624 | SIL1 | SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 327 | 80 | ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 328 | 10436 | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 329 | 9237 | PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 330 | 7983 | NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 331 | 5247 | HSPB2 | heat shock 27kDa protein 2 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 332 | 2928 | DMD | dystrophin (muscular dystrophy, Duchenne and Becker types) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 333 | 8729 | PCNA | proliferating cell nuclear antigen | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 334 | 6886 | MAPK9 | mitogen-activated protein kinase 9 | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 335 | 22948 | NLRP2 | NLR family, pyrin domain containing 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 336 | 6833 | MAOA | monoamine oxidase A | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 337 | 25888 | KLHL22 | kelch-like 22 (Drosophila) | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 338 | 9577 | PSPH | phosphoserine phosphatase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 339 | 1682 | CD47 | CD47 molecule | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 340 | 6115 | IREB2 | iron-responsive element binding protein 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 341 | 11181 | SOD3 | superoxide dismutase 3, extracellular | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 342 | 12649 | VAPB | VAMP (vesicle-associated membrane protein)-associated protein B and C | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 343 | 7414 | MT-ATP6 | mitochondrially encoded ATP synthase 6 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 344 | 9567 | PSMD9 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 345 | 21528 | DIABLO | diablo homolog (Drosophila) | 2 | 170 | 1 | 1 | 1 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 346 | 14078 | BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | 1 | 171 | 0 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 347 | 48 | ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 348 | 7456 | MT-ND2 | mitochondrially encoded NADH dehydrogenase 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 349 | 4312 | GCLM | glutamate-cysteine ligase, modifier subunit | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 350 | 12008 | TPH1 | tryptophan hydroxylase 1 (tryptophan 5-monooxygenase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 351 | 670 | RHOD | ras homolog gene family, member D | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 352 | 7714 | NDUFS7 | NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 353 | 7889 | NOX1 | NADPH oxidase 1 | 2 | 170 | 2 | 0 | 2 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 354 | 592 | XIAP | X-linked inhibitor of apoptosis | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 355 | 12814 | XPA | xeroderma pigmentosum, complementation group A | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 356 | 3769 | FMO1 | flavin containing monooxygenase 1 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 357 | 16860 | SART3 | squamous cell carcinoma antigen recognized by T cells 3 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 358 | 12791 | WRN | Werner syndrome | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 359 | 2294 | COX8A | cytochrome c oxidase subunit 8A (ubiquitous) | 3 | 169 | 3 | 0 | 2 | 2 | 166 | 1.00 | 0.02 | 0.01 | 1.5 |
| 360 | 2197 | COL1A1 | collagen, type I, alpha 1 | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 361 | 12015 | TPO | thyroid peroxidase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 362 | 3701 | FHIT | fragile histidine triad gene | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 363 | 4556 | GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 364 | 7688 | NDUFA5 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 365 | 13716 | C4orf6 | chromosome 4 open reading frame 6 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 366 | 9391 | PRKAR2A | protein kinase, cAMP-dependent, regulatory, type II, alpha | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 367 | 26515 | COQ10A | coenzyme Q10 homolog A (S. cerevisiae) | 3 | 169 | 2 | 1 | 1 | 2 | 166 | 1.00 | 0.02 | 0.01 | 1.5 |
| 368 | 9175 | POLD1 | polymerase (DNA directed), delta 1, catalytic subunit 125kDa | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 369 | 14537 | NPC2 | Niemann-Pick disease, type C2 | 2 | 170 | 0 | 2 | 0 | 2 | 166 | 1.00 | 0.01 | 0.01 | 1.0 |
| 370 | 29884 | UBASH3B | ubiquitin associated and SH3 domain containing, B | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 371 | 7896 | NPAT | nuclear protein, ataxia-telangiectasia locus | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 372 | 12442 | TYR | tyrosinase (oculocutaneous albinism IA) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 373 | 12024 | CRISP2 | cysteine-rich secretory protein 2 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 374 | 7230 | MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 375 | 4805 | HAGH | hydroxyacylglutathione hydrolase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 376 | 11283 | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 377 | 6848 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 378 | 5238 | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 379 | 8125 | OGG1 | 8-oxoguanine DNA glycosylase | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 380 | 6782 | MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 381 | 7461 | MT-ND5 | mitochondrially encoded NADH dehydrogenase 5 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 382 | 7891 | NOX4 | NADPH oxidase 4 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 383 | 25361 | ARHGAP24 | Rho GTPase activating protein 24 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 384 | 9352 | PRDX1 | peroxiredoxin 1 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 385 | 17772 | TXN2 | thioredoxin 2 | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 386 | 17598 | UBE2J1 | ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 387 | 9704 | PVALB | parvalbumin | 2 | 170 | 2 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |
| 388 | 5465 | IGF1R | insulin-like growth factor 1 receptor | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 389 | 12950 | SF1 | splicing factor 1 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 390 | 4141 | GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 6 | 166 | 5 | 1 | 5 | 6 | 162 | 1.00 | 0.03 | 0.04 | 1.0 |
| 391 | 9308 | PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 392 | 4455 | GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 393 | 10944 | SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 394 | 1515 | CAST | calpastatin | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 395 | 12405 | TTR | transthyretin (prealbumin, amyloidosis type I) | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 396 | 6206 | JUND | jun D proto-oncogene | 1 | 171 | 1 | 0 | 1 | 1 | 167 | 1.00 | 0.01 | 0.01 | 1.0 |
| 397 | 8808 | PDHB | pyruvate dehydrogenase (lipoamide) beta | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 398 | 34 | ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 1 | 171 | 1 | 0 | 0 | 0 | 168 | 1.00 | 0.01 | 0.00 | bZero |
| 399 | 4817 | HARS2 | histidyl-tRNA synthetase 2, mitochondrial (putative) | 2 | 170 | 1 | 1 | 0 | 1 | 167 | 1.00 | 0.01 | 0.01 | 2.0 |